Valuation check: HYPMY's profit margin is 20.08%, above the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for HYPMY is 20.08% as of September 2026. That compares with 11.82% in the prior-year period — up 70.0% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Hypera S.A.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, HYPMY's profit margin moved from 11.82% to 20.08% — a 70.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Hypera S.A.'s valuation or profitability profile.
Against Healthcare companies, HYPMY currently prints 20.08% for profit margin, while the sector average sits near 9.48%. That is roughly 111.8% above the sector mean. Large gaps often invite a closer look at Hypera S.A.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Hypera S.A. converts resources into returns. At 20.08%, HYPMY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 11.82% in the prior-year period — up 70.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting HYPMY's profit margin (20.08%), review year-over-year change from 11.82%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.